We kick off this new season with a medical breakthrough story you might THINK you know, but isn't that straightforward. We dive into how the "speedy" development of mRNA vaccines is actually a story with decades of twists and turns. In this episode we look at the mRNA technology that is behind many COVID-19 vaccines, and how an idea that once looked like it was destined to fail got a new life just in time to save so many of ours.

Featuring:

• Dr. Thomas Madden is a biochemist and founder and CEO of Acuitas Therapeutics
• Mike Yee is Jefferies’ managing director and senior biotech analyst
• Joe Miller is a reporter for the Financial Times and the author of The Vaccine: Inside the Race to Conquer the COVID-19 Pandemic